Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Return on Sales (2020 - 2023)

Immuneering has reported Return on Sales over the past 4 years, most recently at 115883.27% for Q3 2023.

  • Quarterly results put Return on Sales at 115883.27% for Q3 2023, down 11554546.0% from a year ago — trailing twelve months through Sep 2023 was 115883.27% (down 11578796.0% YoY), and the annual figure for FY2022 was 159.37%, down 14325.0%.
  • Return on Sales for Q3 2023 was 115883.27% at Immuneering, down from 1355.0% in the prior quarter.
  • Over the last five years, Return on Sales for IMRX hit a ceiling of 6.44% in Q3 2020 and a floor of 115883.27% in Q3 2023.
  • Median Return on Sales over the past 4 years was 63.76% (2021), compared with a mean of 10562.62%.
  • Biggest five-year swings in Return on Sales: crashed -461bps in 2021 and later tumbled -11554546bps in 2023.
  • Immuneering's Return on Sales stood at 8.77% in 2020, then plummeted by -560bps to 57.88% in 2021, then crashed by -51047bps to 29601.84% in 2022, then plummeted by -291bps to 115883.27% in 2023.
  • The last three reported values for Return on Sales were 115883.27% (Q3 2023), 1355.0% (Q2 2023), and 388.62% (Q1 2023) per Business Quant data.